Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Hyperbaric oxygen treatment of mandibular osteoradionecrosis: Combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinical oncology module for the ESTRO core curriculum

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Non-aspirin NSAIDs and head and neck cancer mortality in a Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

PURPOSE: Osteoradionecrosis (ORN) of the mandible is a serious complication of head and neck radiotherapy. This study aims to investigate the effect of hyperbaric oxygen (HBO) treatment on ORN in two randomized, controlled multicentre trials.

METHODS AND MATERIALS: Patients with ORN with indication for surgical treatment were randomised to either group 1: surgical removal of necrotic mandibular bone supplemented by 30 pre- and 10 postoperative HBO exposures at 243 kPa for 90 min each, or group 2: surgical removal of necrotic bone only. Primary outcome was healing of ORN one year after surgery evaluated by a clinically adjusted version of the Common Toxicity Criteria of Adverse Events (CTCAE) v 3.0. Secondary outcomes included xerostomia, unstimulated and stimulated whole salivation rates, trismus, dysphagia, pain, Activities of Daily Living (ADL) and quality of life according to EORTC. Data were combined from two separate trials. Ninety-seven were enrolled and 65 were eligible for the intent-to-treat analysis. The 33% drop-out was equally distributed between groups.

RESULTS: In group 1, 70% (21/30) healed compared to 51% (18/35) in group 2. HBO was associated with an increased chance of healing independent of baseline ORN grade or smoking status as well as improved xerostomia, unstimulated whole salivary flow rate, and dysphagia. Due to insufficient recruitment, none of the endpoints reached a statistically significant difference between groups. ADL data could only be obtained from 50 patients.

CONCLUSION: Hyperbaric oxygen did not significantly improve the healing outcome of osteoradionecrosis after surgical removal of necrotic bone as compared to standard care (70% vs. 51%). This effect is not statistically significant due to the fact that the study was underpowered and is therefore prone to type II error.

Original languageEnglish
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Pages (from-to)137-144
Number of pages8
Publication statusPublished - Jan 2022

Bibliographical note

Copyright © 2021. Published by Elsevier B.V.

    Research areas

  • Head and neck cancer, Hyperbaric oxygen treatment, Mandible, Osteoradionecrosis, Radiation therapy, Randomised clinical trial

ID: 69402906